Regulus therapeutics inc

Major-Pharmaceuticals

RGLS


10614 Science Center Drive
San Diego , CA 92121

Executive/
Director

Price

  • Last Close
  • $ 1.59
    $ +0.08 5.3 %
    Dec 6, 2024
  • 52-Week High/Low
  • $2.89 - $1.13
  • YTD
  • 24.2%

  • Trading Volume
  • 8,654
  • Market Cap Full
  • $ 32.2M
  • Shares Outstanding
  • 20.2M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 5.6% -20.5% -26.7% -31% 9.7% -5% 15.6% -6.8% -38.1% 125%
Q2 -35.3% -58.3% -40.3% - 20.4% 4% -48.1% 590% 73.4% -
Q3 -40.3% 14.2% 26.8% -72.2% -47.1% 8% -14.7% -17.9% -6.1% -
Q4 33.3% -31.8% -21.2% -61.3% 16.2% 164.7% -53.4% -19.4% -7.3% -
J F M A M J J A S O N D
2024 -0.8% 15.8% 95.9% -2.8% - - - - - - - -
2023 5.1% -6.9% -36.7% 56.8% -2.3% 13.1% -4.8% 11.4% -11.5% -11.6% 8.2% -3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    117%-46%-74%-54%-93%-13%66%-76%325%-7%24%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.25 0.40 0.38 -1.81 -0.31 -0.25 -0.08 -0.5 -0.42
Q2 0.41 0.40 0.41 -1.57 -0.3 -0.23 -0.08 -0.5 -0.37
Q3 0.25 0.37 0.18 -1.18 -0.26 -0.04 -0.1 -0.5 -0.40
Q4 0.14 0.38 0.14 -1.04 -0.21 0.07 -0.67 -0.36 -
A 1.1 1.6 1.1 -5.6 -1.1 -0.5 3.2 1.9 -1.19

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 10.7 21 72.5 146 16.8
Jun 104.3 20.5 27.6 74.9 146 19.5
Sep 104.8 20.8 35.9 87 14.6 19.5
Dec 8.8 20.9 39.2 87 16.8 20.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - 7 -
Total Asset Turnover - - 0.3 0.2 -
Leverage
Debt Ratio - 0.1 - - -
Debt – Equity Ratio - 0.1 - - -
Interest Coverage - - -7 -8.5 -23.5
Equity multiplier - - - 0.1 -1.3